Product Information
CABERGOLINE 0.5 MG TABLET is a generic product labeled by Somerset Therapeutics, LLC, priced at $1.3455 per EA under NDC 70069082408. Its NADAC has been published 78 times since Feb 26, 2025.
FDA first approved this application on Sep 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Somerset Therapeutics, LLCNDC
70069082408
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CABERGOLINEApproval Type
Generic (ANDA)
FDA Application
ANDA218109FDA Approved
9/9/2024
TE Code
AB
On Market Since
10/18/2024
Pharmacological Classes
Price Statistics
The NADAC for CABERGOLINE 0.5 MG TABLET has been published 78 times since Feb 26, 2025, and over the history we have for it it has declined 9.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3455 per EA |
|---|---|
| All-time high | $1.6393 (Jun 11, 2025) |
| All-time low | $1.3455 (Aug 19, 2026) |
| 52-week high | $1.5270 |
| 52-week low | $1.3455 |
| Median price | $1.4724 |
| Average price | $1.4840 |
| Largest weekly change | +9.1% (Mar 19, 2025) |
| Weeks tracked | 78 |
| Tracking since | Feb 26, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CABERGOLINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CABERGOLINE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CABERGOLINE 0.5 MG TABLET, manufactured by Somerset Therapeutics, LLC, is $1.3455 per EA (NDC 70069082408), effective Aug 19, 2026.
How has the price of CABERGOLINE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CABERGOLINE 0.5 MG TABLET has declined 9.0%. It has been tracked across 78 weekly CMS publications since Feb 26, 2025.
What are the highest and lowest recorded NADAC prices for CABERGOLINE 0.5 MG TABLET?
Since Feb 26, 2025, the NADAC for CABERGOLINE 0.5 MG TABLET has ranged from a low of $1.3455 (Aug 19, 2026) to a high of $1.6393 (Jun 11, 2025), with a median of $1.4724 per EA.
Are there cheaper alternatives to CABERGOLINE 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CABERGOLINE 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CABERGOLINE 0.5 MG TABLET?
CABERGOLINE 0.5 MG TABLET (NDC 70069082408) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.